Lv6
2780 积分 2024-01-17 加入
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
2天前
已完结
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule
17天前
已关闭
Phase I trial of gemcitabine given as an intravenous bolus on five consecutive days
17天前
已关闭
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
3个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
3个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
3个月前
已完结
diagnosis and management of AML in adults：2022 recommendation from an international expert panel on behalf of the ELN
6个月前
已完结
A review of treatment options employed in relapsed/refractory AML
9个月前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
9个月前
已完结
The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical review
9个月前
已完结
皖公网安备34019202002308
